Ibuprofen. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what. Updated January 18, 2013. Accessed January 18, 2013.
Antipsychotics. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what. Updated November 25, 2012. Accessed January 17, 2013.
Cocaine abuse. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what. Updated November 9, 2012. Accessed January 17, 2013.
COX-2 inhibitors. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what. Updated January 26, 2012. Accessed January 17, 2013.
Dextroamphetamine. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what. Updated August 6, 2012. Accessed January 17, 2013.
DrugFacts: Anabolic Steroids. National Institute on Drug Abuse website. Available at: http://www.drugabuse.gov/publications/drugfacts/anabolic-steroids. Updated July 2012. Accessed January 17, 2013.
DrugFacts: Club Drugs (GHB, Ketamine, and Rohypnol). National Institute on Drug Abuse website. Available at: http://www.drugabuse.gov/publications/drugfacts/club-drugs-ghb-ketamine-rohypnol. Updated July 2010. Accessed January 17, 2013.
Gislason GH, Jacobsen S, Rasmussen JN, et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal anti-inflammatory drugs after acute myocardial infarction.
Circulation.
2006;113:2906-2913.
Glucose lowering medications for type 2 diabetes. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what. Updated January 16, 2013. Accessed January 17, 2013.
Jensen BV. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
Semin Oncol.
2006;33:S15-21.
Koro CE, Bowlin SJ, Weiss SR. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
Pharmacoepidemiol Drug Saf.
2005;14:697-703.
Loke Y, Derry S, Pritchard-Copley A. Appetite suppressants and valvular heart disease—a systematic review.
BMC Clin Pharmacol. 2002;2:6.
MDMA (Ecstasy). National Institute on Drug Abuse. Available at: http://www.drugabuse.gov/publications/drugfacts/mdma-ecstasy. Updated December 2012. Accessed January 17, 2013.
Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors
. JAMA.
2001;286:954-959.
Neuteufl T, Heher S, Kostner K, et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers.
Journal of the American College of Cardiology.
2002;39:251-256.
Taubert KA. Cardiology patient pages. Can patients with cardiovascular disease take nonsteroidal antiinflammatory drugs? Circulation. 2008;117(17):e322-e324.
Testosterone. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php. Updated April 11, 2011. Accessed January 17, 2013.
Tobacco use disorder. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php. Updated January 9, 2013. Accessed January 17, 2013.
Toxicities of chemotherapeutic agents. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php. Updated January 14, 2013. Accessed January 17, 2013.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.